Ceryvyn Therapeutics Limited (ASX:CYV)
Australia · Delayed Price · Currency is AUD 0.0100
0.00 (0.00%)
Oct 29, 2026, 4:10 PM AEDT
Ceryvyn Therapeutics Market Cap
Ceryvyn Therapeutics has a market cap or net worth of 13.68 million as of October 29, 2026. It is the 41,666th most valuable company in the world and the 1,206th biggest in Australia. Its market cap has decreased by 98.15% in one year.
Market Cap
13.68M
Enterprise Value
-16.34M
Revenue
1.00K
Global Rank
Country Rank
#1,206 Australia
PE Ratio
0.04
ChartMarket Cap Chart
Since May 13, 1996, Ceryvyn Therapeutics's market cap has decreased from 39.30M to 13.68M, a decrease of -65.19%. That is a compound annual growth rate of -3.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 13.68M | -98.63% |
| Dec 31, 2024 | 997.31M | 163.98% |
| Dec 29, 2023 | 377.80M | -11.57% |
| Dec 30, 2022 | 427.23M | -6.26% |
| Dec 31, 2021 | 455.76M | -29.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Algorae Pharmaceuticals | 18.25M |
| Proteomics International Laboratories | 18.19M |
| Imugene | 17.63M |
| Radiopharm Theranostics | 17.35M |
| ReNerve | 15.51M |
| Noxopharm | 15.05M |
| EZZ Life Science Holdings | 14.59M |
| Patrys | 14.56M |